fda drug shortages tirzepatide zepbound shortage status 2025 Lilly's weight-loss removed from FDA's list FDA approval for Zepbound (tirzepatide)

Lower doses might avoid common side effects seen with full-dose tirzepatide, such as nausea or gastrointestinal discomfort

In a recent study, patients taking Semaglutide achieved an average weight loss of 15.2% over one year, while those taking Tirzepatide experienced an average weight loss of 15.7%

It works by mimicking the GLP-1 hormone to regulate hunger signals and enhance metabolic function

Food just stopped being this constant background noise in my head

One important piece of evidence comes from examining the fitness outcomes of people losing weight on GLP-1 drugs

Aging : Aging is associated with a natural increase in visceral fat and redistribution of body fat from peripheral to central depots